about
A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural AlertsMicroencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugsDNA polymerases as therapeutic targetsDevelopment of cytarabine prodrugs and delivery systems for leukemia treatment.Identification of Nucleoside Analogs as Inducers of Neuronal Differentiation in a Human Reporter Cell Line and Adult Stem Cells.Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
P2860
Q28820944-D51CE8B3-8A42-47BA-8C3C-5C2681C639F2Q33514058-54BFD95F-5FFB-4FAD-9492-3552BE861D83Q33997393-3F1C90C4-E001-4169-931A-FF2B0B34D438Q37216862-1AFE5601-6D25-4F37-A016-4CF56666AFA1Q37801934-CFF3DB84-B382-4A1C-9CF9-4420A8C35563Q38936117-7EC1419C-449B-4C67-817B-45D4C41634DEQ43245706-6F4294D1-4F0F-4896-B20F-BBAF374CE3D2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nucleoside analogue delivery systems in cancer therapy.
@en
type
label
Nucleoside analogue delivery systems in cancer therapy.
@en
prefLabel
Nucleoside analogue delivery systems in cancer therapy.
@en
P2093
P2860
P356
P1476
Nucleoside analogue delivery systems in cancer therapy.
@en
P2093
Charles Dumontet
Ghania Degobert
Hatem Fessi
Misara Hamoudeh
Roudayna Diab
P2860
P304
P356
10.1517/17425247.4.5.513
P407
P577
2007-09-01T00:00:00Z